Ensign Peak Advisors’s Integra LifeSciences IART Stock Holding History

Ensign Peak Advisors’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$113K	Buy	6,312 +550	+10%	+$7.69K	﹤0.01%	1583
2026 Q1	$54.3K	Hold	5,762	–	–	﹤0.01%	1671
2025 Q4	$71.6K	Sell	5,762 -14,150	-71%	-$188K	﹤0.01%	1635
2025 Q3	$285K	Hold	19,912	–	–	﹤0.01%	1586
2025 Q2	$244K	Hold	19,912	–	–	﹤0.01%	1666
2025 Q1	$438K	Hold	19,912	–	–	﹤0.01%	1579
2024 Q4	$452K	Hold	19,912	–	–	﹤0.01%	1626
2024 Q3	$362K	Hold	19,912	–	–	﹤0.01%	1663
2024 Q2	$580K	Hold	19,912	–	–	﹤0.01%	1559
2024 Q1	$706K	Sell	19,912 -1,004	-5%	-$40.2K	﹤0.01%	1520
2023 Q4	$911K	Hold	20,916	–	–	﹤0.01%	1439
2023 Q3	$799K	Hold	20,916	–	–	﹤0.01%	1364
2023 Q2	$860K	Hold	20,916	–	–	﹤0.01%	1382
2023 Q1	$1.2M	Buy	20,916 +550	+3%	+$31K	﹤0.01%	1094
2022 Q4	$1.14M	Sell	20,366 -5,100	-20%	-$260K	﹤0.01%	1058
2022 Q3	$1.08M	Hold	25,466	–	–	﹤0.01%	1027
2022 Q2	$1.38M	Hold	25,466	–	–	﹤0.01%	965
2022 Q1	$1.64M	Hold	25,466	–	–	﹤0.01%	954
2021 Q4	$1.71M	Sell	25,466 -34,960	-58%	-$2.37M	﹤0.01%	1024
2021 Q3	$4.14M	Hold	60,426	–	–	0.01%	733
2021 Q2	$4.12M	Buy	60,426 +3,900	+7%	+$276K	0.01%	730
2021 Q1	$3.9M	Sell	56,526 -10,617	-16%	-$719K	0.01%	736
2020 Q4	$4.36M	Hold	67,143	–	–	0.01%	661
2020 Q3	$3.17M	Hold	67,143	–	–	0.01%	759
2020 Q2	$3.15M	Hold	67,143	–	–	0.01%	751
2020 Q1	$3M	Buy	67,143 +7,176	+12%	+$377K	0.01%	665
2019 Q4	$3.5M	Buy	+59,967	New	+$3.57M	0.01%	770

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Ensign Peak Advisors's IART Position: Q2 2026 in Review

Ensign Peak Advisors increased its Integra LifeSciences (IART) stake by 9.5% in Q2 2026, buying an estimated $7.69K and bringing the position to 6,312 shares worth $113K. The position accounts for ﹤0.01% of the portfolio, ranked #1583.

Ensign Peak Advisors first reported a position in IART in Q4 2019 and has held it in 27 quarters since. The position peaked at $4.36M in Q4 2020. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

Ensign Peak Advisors held 6,312 shares of Integra LifeSciences worth $113K as of Q2 2026.
Ensign Peak Advisors bought 550 Integra LifeSciences shares in Q2 2026, an estimated $7.69K.
Integra LifeSciences made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #1583 holding.
Ensign Peak Advisors first reported a position in Integra LifeSciences in Q4 2019 and has held it in 27 quarters since.
Ensign Peak Advisors's Integra LifeSciences position peaked at $4.36M in Q4 2020.
212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.